TDP1 repairs nuclear and mitochondrial DNA damage induced by chain-terminating anticancer and antiviral nucleoside analogs

Nucleic Acids Research

Volumn 41, Issue 16, 2013, Pages 7793-7803

  Huang, Shar Yin N ^a   Murai, Junko ^a,b   Dalla Rosa, Ilaria ^a   Dexheimer, Thomas S ^c   Naumova, Alena ^a   Gmeiner, William H ^d   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CELL NUCLEUS DNA; CHAIN TERMINATING NUCLEOSIDE DERIVATIVE; CYTARABINE; MITOCHONDRIAL DNA; NUCLEOSIDE DERIVATIVE; PHOSPHODIESTERASE; TYROSYL DNA PHOSPHODIESTERASE 1; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC ANTIMETABOLITE; TDP1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BIOACCUMULATION; CHEMOSENSITIVITY; CONTROLLED STUDY; COVALENT BOND; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DRUG EFFECT; GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; TDP1 GENE; ANIMAL; CELL CULTURE; CELL LINE; CELL NUCLEUS; CHICKEN; DNA REPAIR; GENE DELETION; GENETICS; METABOLISM; MOUSE;

ACYCLOVIR; ANIMALS; ANTI-HIV AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTIVIRAL AGENTS; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; CHICKENS; CYTARABINE; DNA DAMAGE; DNA REPAIR; DNA, MITOCHONDRIAL; GENE DELETION; MICE; PHOSPHORIC DIESTER HYDROLASES; ZALCITABINE; ZIDOVUDINE;

EID: 84886828375     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt483     Document Type: Article

References (55)

1. De Clercq,E. and Field,H.J. (2006) Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol., 147, 1-11.
2. Berdis,A.J. (2008) DNA polymerases as therapeutic targets. Biochemistry, 47, 8253-8260.
3. Schaeffer,H.J., Beauchamp,L., de Miranda,P., Elion,G.B., Bauer,D.J. and Collins,P. (1978) 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature, 272, 583-585.
4. Rashbaum,S.A. and Cozzarelli,N.R. (1976) Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine. Nature, 264, 679-680.
5. Mitsuya,H., Yarchoan,R. and Broder,S. (1990) Molecular targets for AIDS therapy. Science, 249, 1533-1544.
6. Nickel,W., Austermann,S., Bialek,G. and Grosse,F. (1992) Interactions of azidothymidine triphosphate with the cellular DNA polymerases alpha, delta, and epsilon and with DNA primase. J. Biol. Chem., 267, 848-854.
7. Johnson,A.A., Ray,A.S., Hanes,J., Suo,Z., Colacino,J.M., Anderson,K.S. and Johnson,K.A. (2001) Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem., 276, 40847-40857.
8. Lee,H., Hanes,J. and Johnson,K.A. (2003) Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry, 42, 14711-14719.
9. Iwasaki,H., Huang,P., Keating,M.J. and Plunkett,W. (1997) Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells. Blood, 90, 270-278.
10. Richardson,K.A., Vega,T.P., Richardson,F.C., Moore,C.L., Rohloff,J.C., Tomkinson,B., Bendele,R.A. and Kuchta,R.D. (2004) Polymerization of the triphosphates of AraC, 20,20- difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase. Biochem. Pharmacol., 68, 2337-2346.
11. Prakasha Gowda,A.S., Polizzi,J.M., Eckert,K.A. and Spratt,T.E. (2010) Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1. Biochemistry, 49, 4833-4840.
12. Sampath,D., Rao,V.A. and Plunkett,W. (2003) Mechanisms of apoptosis induction by nucleoside analogs. Oncogene, 22, 9063-9074.
13. Lewis,W., Day,B.J. and Copeland,W.C. (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev. Drug Discov., 2, 812-822.
14. Hanes,J.W. and Johnson,K.A. (2007) A novel mechanism of selectivity against AZT by the human mitochondrial DNA polymerase. Nucleic Acids Res., 35, 6973-6983.
15. Pouliot,J.J., Yao,K.C., Robertson,C.A. and Nash,H.A. (1999) Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science, 286, 552-555.
16. Hirano,R., Interthal,H., Huang,C., Nakamura,T., Deguchi,K., Choi,K., Bhattacharjee,M.B., Arimura,K., Umehara,F., Izumo,S. et al. (2007) Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation? EMBO J., 26, 4732-4743.
17. Das,B.B., Antony,S., Gupta,S., Dexheimer,T.S., Redon,C.E., Garfield,S., Shiloh,Y. and Pommier,Y. (2009) Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J., 28, 3667-3680.
18. Fu,X., Wan,S., Lyu,Y.L., Liu,L.F. and Qi,H. (2008) Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PloS One, 3, e2009.
19. Miao,Z.H., Agama,K., Sordet,O., Povirk,L., Kohn,K.W. and Pommier,Y. (2006) Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes. DNA Repair, 5, 1489-1494.
20. El-Khamisy,S.F., Saifi,G.M., Weinfeld,M., Johansson,F., Helleday,T., Lupski,J.R. and Caldecott,K.W. (2005) Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature, 434, 108-113.
21. Zhou,T., Lee,J.W., Tatavarthi,H., Lupski,J.R., Valerie,K. and Povirk,L.F. (2005) Deficiency in 30-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res., 33, 289-297.
22. Das,B.B., Dexheimer,T.S., Maddali,K. and Pommier,Y. (2010) Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria. Proc. Natl Acad. Sci. USA, 107, 19790-19795.
23. Murai,J., Huang,S.N., Das,B.B., Dexheimer,T.S., Takeda,S. and Pommier,Y. (2012) Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells. J. Biol. Chem., 287, 12848-12857.
24. Takashima,H., Boerkoel,C.F., John,J., Saifi,G.M., Salih,M.A.M., Armstrong,D., Mao,Y., Quiocho,F.A., Roa,B.B., Nakagawa,M. et al. (2002) Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet., 32, 267-272.
25. Katyal,S., el-Khamisy,S.F., Russell,H.R., Li,Y., Ju,L., Caldecott,K.W. and McKinnon,P.J. (2007) TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J., 26, 4720-4731.
26. Dexheimer,T.S., Stephen,A.G., Fivash,M.J., Fisher,R.J. and Pommier,Y. (2010) The DNA binding and 30-end preferential activity of human tyrosyl-DNA phosphodiesterase. Nucleic Acids Res., 38, 2444-2452.
27. Antony,S., Marchand,C., Stephen,A.G., Thibaut,L., Agama,K.K., Fisher,R.J. and Pommier,Y. (2007) Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl- DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res., 35, 4474-4484.
28. Dexheimer,T.S., Antony,S., Marchand,C. and Pommier,Y. (2008) Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med. Chem., 8, 381-389.
29. Interthal,H., Chen,H.J. and Champoux,J.J. (2005) Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages. J. Biol. Chem., 280, 36518-36528.
30. Yang,S.W., Burgin,A.B., Huizenga,B.N., Robertson,C.A., Yao,K.C. and Nash,H.A. (1996) A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl Acad. Sci. USA, 93, 11534-11539.
31. Raymond,A.C., Staker,B.L. and Burgin,A.B. (2005) Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1). J. Biol. Chem., 280, 22029-22035.
32. Raymond,A.C., Rideout,M.C., Staker,B., Hjerrild,K. and Burgin,A.B. (2004) Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues. J. Mol. Biol., 338, 895-906.
33. Kim,H., Na,S.H., Lee,S.Y., Jeong,Y.M., Hwang,H.J., Hur,J.Y., Park,S.H., Woo,J.C. and Kim,S.G. (2012) Structure-function studies of a plant tyrosyl-DNA phosphodiesterase provide novel insights into DNA repair mechanisms of Arabidopsis thaliana. Biochemical. J., 443, 49-56.
34. Gottlin,E.B., Rudolph,A.E., Zhao,Y., Matthews,H.R. and Dixon,J.E. (1998) Catalytic mechanism of the phospholipase D superfamily proceeds via a covalent phosphohistidine intermediate. Proc. Natl Acad. Sci. USA, 95, 9202-9207.
35. Huang,P., Chubb,S., Hertel,L.W., Grindey,G.B. and Plunkett,W. (1991) Action of 20,20-difluorodeoxycytidine on DNA synthesis. Cancer Res., 51, 6110-6117.
36. Chen,C.H. and Cheng,Y.C. (1989) Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the antihuman immunodeficiency virus compound 20,30-dideoxycytidine. J. Biol. Chem., 264, 11934-11937.
37. Lim,S.E. and Copeland,W.C. (2001) Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J. Biol. Chem., 276, 23616-23623.
38. Feng,J.Y., Johnson,A.A., Johnson,K.A. and Anderson,K.S. (2001) Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J. Biol. Chem., 276, 23832-23837.
39. Fam,H.K., Chowdhury,M.K., Walton,C., Choi,K., Boerkoel,C.F. and Hendson,G. (2013) Expression profile and mitochondrial colocalization of Tdp1 in peripheral human tissues. J. Mol. Histol., 44, 481-494.
40. Interthal,H., Chen,H.J., Kehl-Fie,T.E., Zotzmann,J., Leppard,J.B. and Champoux,J.J. (2005) SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity. EMBO J., 24, 2224-2233.
41. Beutner,K.R., Friedman,D.J., Forszpaniak,C., Andersen,P.L. and Wood,M.J. (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother., 39, 1546-1553.
42. Soul-Lawton,J., Seaber,E., On,N., Wootton,R., Rolan,P. and Posner,J. (1995) Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob. Agents Chemother., 39, 2759-2764.
43. Powis,G. (1983) Dose-dependent metabolism, therapeutic effect, and toxicity of anticancer drugs in man. Drug Metab. Rev., 14, 1145-1163.
44. Capizzi,R.L., White,J.C., Powell,B.L. and Perrino,F. (1991) Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Sem. Hematol., 28, 54-69.
45. Davies,D.R., Interthal,H., Champoux,J.J. and Hol,W.G. (2003) Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. Chem. Biol., 10, 139-147.
46. Plo,I., Liao,Z.Y., Barcelo,J.M., Kohlhagen,G., Caldecott,K.W., Weinfeld,M. and Pommier,Y. (2003) Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions. DNA Repair, 2, 1087-1100.
47. Hudson,J.J., Chiang,S.C., Wells,O.S., Rookyard,C. and El- Khamisy,S.F. (2012) SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair. Nat. Commun., 3, 733.
48. Major,P.P., Egan,E.M., Beardsley,G.P., Minden,M.D. and Kufe,D.W. (1981) Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc. Natl Acad. Sci. USA, 78, 3235-3239.
49. Takahashi,T., Min,Z., Uchida,I., Arita,M., Watanabe,Y., Koi,M. and Hemmi,H. (2005) Hypersensitivity in DNA mismatch repairdeficient colon carcinoma cells to DNA polymerase reaction inhibitors. Cancer Lett., 220, 85-93.
50. Fordham,S.E., Matheson,E.C., Scott,K., Irving,J.A.E. and Allan,J.M. (2011) DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs. Leukemia, 25, 1046-1049.
51. Wu,Q., Beland,F.A., Chang,C.W. and Fang,J.L. (2011) XPC is essential for nucleotide excision repair of zidovudine-induced DNA damage in human hepatoma cells. Toxicol. Appl. Pharmacol., 251, 155-162.
52. Pourquier,P., Takebayashi,Y., Urasaki,Y., Gioffre,C., Kohlhagen,G. and Pommier,Y. (2000) Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells. Proc. Natl Acad. Sci. USA, 97, 1885-1890.
53. Pourquier,P., Gioffre,C., Kohlhagen,G., Urasaki,Y., Goldwasser,F., Hertel,L.W., Yu,S., Pon,R.T., Gmeiner,W.H. and Pommier,Y. (2002) Gemcitabine (20,20-difluoro-20-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin. Cancer Res., 8, 2499-2504.
54. Huang,S.N., Pommier,Y. and Marchand,C. (2011) Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors. Expert Opin. Ther. Pat., 21, 1285-1292.
55. Zhang,Y.W., Regairaz,M., Seiler,J.A., Agama,K.K., Doroshow,J.H. and Pommier,Y. (2011) Poly(ADP-ribose) polymerase and XPF-ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells. Nucleic Acids Res., 39, 3607-3620.